Registration opened today for the 7th CSP Blind Test - the leading challenge in crystal structure prediction. In 1988 Nature editor John Maddox called it "one of the continuing scandals in the physical sciences" that we could not take a 2D molecular structure and predict it's 3D form. This particular puzzle in computational science continues to challenge some of the best practitioners and developers of computational chemistry. Although tech giants have been turning their hand to scientific problems like protein folding, CSP is a very different kind of problem, and might just be a tougher nut to crack.
With every challenge, there is opportunity. Looking into the vast challenge that is COVID-19 it can be difficult to see this, but the pandemic has forced us to contemplate new possibilities in all areas of life, including scientific research.
The world turned to the pharmaceutical industry for help, and the variety of responses makes us question; how did some get ahead while others struggled?